Section Arrow
ATAI.NASDAQ
- AtaiBeckley Inc
Quotes are at least 15-min delayed:2026/04/01 06:45 EDT
Pre Market
Last
 3.57
+0.03 (+0.85%)
Bid
3.56
Ask
3.7
High 3.57 
Low 3.55 
Volume 228 
Regular Hours (Closed)
Last
 3.54
+0.14 (+4.12%)
Day High 
3.61 
Prev. Close
3.4 
1-M High
4.25 
Volume 
3.02M 
Bid
3.56
Ask
3.7
Day Low
3.45 
Open
3.455 
1-M Low
3.265 
Market Cap 
1.23B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.49 
20-SMA 3.62 
50-SMA 3.76 
52-W High 6.75 
52-W Low 1.15 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.83/-0.42
Enterprise Value
1.25B
Balance Sheet
Book Value Per Share
0.44
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
314.00K
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
VRAXVirax Biolabs Group Limited0.2199+0.0574+35.32%-- 
Pre Market 0.19 -0.0299 -13.60%
APLSApellis Pharmaceuticals40.23+23.14+135.40%94.94PE
Pre Market 40.43 +0.2 +0.50%
IOBTIO Biotech0.0587-0.1137-65.95%-- 
Pre Market 0.0498 -0.0089 -15.16%
ITRMIterum Therapeutics plc0.03-0.0404-57.39%-- 
Pre Market -- -- --
ELABPmgc Holdings Inc5.99+2.43+68.26%0PE
Pre Market 7.7229 +1.7329 +28.93%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.